The Effects of Exogenous Ketones on Cognitive Function
University of Alabama at Birmingham · NCT07051655
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 19–55 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 45
- US sites recruiting
- 1
- Study start
- December 1, 2025
- Record last updated
- July 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to evaluate the acute effects of exogenous ketone monoester (KME) supplementation on cognitive function in three groups of adults aged 19-55 years: (1) obese, sedentary individuals; (2) lean, sedentary individuals; and (3) lean individuals who engage in regular physical activity (e.g., collegiate or amateur athletes). The main questions it aims to answer are to:
- Assess the effects of acute KME supplementation versus placebo on cognitive, sensorimotor, and functional outcomes within groups.
- Compare cognitive performance across the three groups.
The primary outcome is cognitive performance assessed using the NIH Toolbox Cognition Battery. Secondary Outcomes include sensorimotor performance, measured using the Senaptec Sensory System, and driving performance, assessed with a driving simulator.
Being studied: Ketone Monoester (KE); Placebo
Conditions: Placebo - Control; Ketone Monoester
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 19-55 years
- BMI 30-40 (obese group) or 18-25 (lean and athlete groups)
- Sedentary status (\<2 hrs/week of structured physical activity) for obese and lean groups
- Active athlete status (≥5 days/week of structured activity) for athlete group
Exclusion Criteria
- Diagnosed neurological conditions (e.g., Parkinson's disease, multiple sclerosis, schizophrenia, muscular dystrophy, stroke, cerebral palsy)
- History of seizures
- Use of medications for diabetes, mood disorders, or attention disorders
- Pregnant or breastfeeding
- Current or recent use (within 1 month) of exogenous ketone supplements or adherence to a ketogenic diet
Recruiting US locations
916 Building
Birmingham, AL 35205
Site contact: Sarah K Sweatt, PhD · 205-975-5398 · sksweatt@uab.edu
Study contacts (from the official record)
- Sarah K Sweatt, PhD · 205-975-5398 · sksweatt@uab.edu
- Eric Plaisance · plaisep@uab.edu
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65